-
As Japan’s cherry trees bloomed and the stock market soared, Kohetsu Watanabe flew to a blossom- viewing party in Tokyo hosted by Prime Minister Shinzo Abe to tell the premier personally how bad things really are.
-
Three former employees of a New York- based university were charged in a bribery scheme tied to research funded under a multi-million dollar grant from the U.S. National Institutes of Health on magnetic resonance imaging.
-
Japanese biotech ventures promising to make jet fuel from algae and to produce synthetic cartilage are soaring in Tokyo trading as cash pumped into the economy by the central bank cascades into speculative investments.
-
The hallucinogen ketamine relieved symptoms of hard-to-treat depression within a day of treatment, in the largest study yet of the popular club drug’s use in psychiatry.
-
Buried in the questions Senate Republicans want answered by the nominee to head the Environmental Protection Agency is a stumper: data linking microscopic particles in the air to premature death.
-
Roche Holding AG’s experimental leukemia drug shrank tumors in more patients when added to chemotherapy, according to study results that may aid the company in expanding its line of blood-cancer treatments.
-
Chemotherapy, radiation and the use of radioactive follow-up tests aren’t needed for some cancers, according to two studies that add to a growing debate on ways to lessen side effects and lower patient costs.
-
Google Inc. Chief Executive Officer Larry Page disclosed a health condition that can result in hoarse speech and labored breathing, though according to doctors won’t impede him from running the Web-search provider.
-
Johnson & Johnson won U.S. approval to use its rheumatoid arthritis drug Simponi to treat patients suffering from a moderate to severe inflammatory bowel disease.
-
Angelina Jolie’s decision to have a double mastectomy is fueling debate among the thousands of women at risk of developing breast cancer who want to know how, if and when to have their breasts removed.
Rate this Page